The appeal should include updated clinical documentation from your doctor, a detailed Letter of Medical Necessity that directly addresses the specific reason for denial, any new medical evidence supporting your need for GLP-1 therapy, and peer-reviewed research supporting the use of GLP-1 medications for your specific condition
patients with type 2 diabetes, comparing semaglutide to seven other diabetes medications, including metformin and insulin
Verze P, Somma A, Imbimbo C, Mansueto G, Mirone V, Insabato L
Polyubiquitination of signaling molecules such as TRAF2, TRAF6, RIP-1, and NEMO activates the TAK1 and IB kinase (IKK) complexes, leading to NF-B activation and pro-inflammatory cytokine production
The molecule is large and breaks down extensively in the digestive tract
Reported reactions included nausea, vomiting, chills, low blood pressure, breathing difficulty and hospitalization, with excessive endotoxin exposure identified as a concern